Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $367.7900 (-2.05%) ($366.3600 - $383.0000) on Tue. Apr. 16, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.73% (three month average) | RSI | 32 | Latest Price | $367.7900(-2.05%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -1.4% a day on average for past five trading days. | Weekly Trend | REGN declines -3% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(59%) XLV(48%) IVW(40%) IWF(40%) QQQ(40%) | Factors Impacting REGN price | REGN will decline at least -0.865% in a week (0% probabilities). UUP(-11%) VXX(-10%) TLT(-6%) IFRA(-6%) TIP(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.865% (StdDev 1.73%) | Hourly BBV | 0 () | Intraday Trend | -2.7% | | | |
|
Resistance Level | $399.2 | 5 Day Moving Average | $385.62(-4.62%) | 10 Day Moving Average | $393.99(-6.65%) | 20 Day Moving Average | $399.2(-7.87%) | To recent high | -16.3% | To recent low | 0% | Market Cap | $38.996b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |